| Literature DB >> 30912420 |
Parthasarathy G1, L Lakshmanan2, L Ramanathan3.
Abstract
Objective: In recent years, citation analysis tools provide many devices for finding or computing the citation score or impact factor for journals. It is important for the researchers to identify good journals for collecting research ideas discussed. A journal with a good impact factor value is preferably referred to by many researchers. In this research work, the author proposes a system for ranking journals on the basis of ideas and results cited in other papers.Entities:
Keywords: Opining mining; citation ranking; citation classification; cancer research journal; Information retrieval
Mesh:
Year: 2019 PMID: 30912420 PMCID: PMC6825762 DOI: 10.31557/APJCP.2019.20.3.951
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Figure 1Medical Journal Ranking System Architecture
Citation Score Measure for Adjective Terms
| Positive Adjective | Score Value | B | Negative Adjective | Score Value |
|---|---|---|---|---|
| Reliable | 0.95 | Fuzzy Measures of Simple Adjectives | Not Good | 0.45 |
| Effective | 0.84 | Utterly | 0.49 | |
| Finely | 0.67 | Acceptable | 0.35 | |
| Adopted | 0.58 | Not Great | 0.25 | |
| Fantastic | 0.88 | Moderate | 0.43 |
Citation Score Measures for Adjective with Adverb
| Positive Adjective with Adverb | Score | E | Negative Adjective with Adverb | Score |
|---|---|---|---|---|
| More reliable | 0.95 | Fuzzy Measures of Adjectives with Adverb | Unfortunately | 0.45 |
| More useful | 0.84 | Not a useful | 0.49 | |
| Well adopted | 0.67 | Not supported | 0.35 | |
| Relatively better | 0.58 | Unexpectedly | 0.25 | |
| Good idea | 0.88 | Poor quality research | 0.43 |
Input Key Terms for Collecting Citations fFrom Digital Libraries
| Keyword | Number of Papers Since 2014 | Number of Citations |
|---|---|---|
| Breast cancer | 364,000 | 20,516 |
| Brain cancer | 368,000 | 39,900 |
| Kidney cancer | 216,000 | 8,829 |
| Liver cancer | 319,000 | 16,821 |
| Lung cancer | 316,000 | 3,900 |
| Pancreatic cancer | 120,000 | 35,886 |
| Skin cancer | 343,000 | 6,641 |
| Thyroid cancer | 47,000 | 24,921 |
| Ovarian cancer | 98,600 | 11,456 |
| Total | 168,870 |
Cited Papers and Its Citation Counts
| Paper ID | Paper Title | Citation Count |
|---|---|---|
| P1 | Recurrent and functional regulatory mutations in breast cancer, E Rheinbay. et al. (2017). | 18 |
| P2 | Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer, T Kitai. et al. (2005). | 155 |
| P3 | Gene expression profiling predicts clinical outcome of breast cancer, LJ Van’t Veer. et al. (2002). | 9,091 |
| P4 | Prospective identification of tumorigenic breast cancer cells, R .Wooster. et al. (1995). | 9,384 |
| P5 | Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer , DJ Slamon. et al. (1989). | 7,379 |
| P6 | PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer , J Li. et al. (1997). | 5,669 |
| P7 | Global burden of breast cancer , J Ferlay. et al. (2010). | 2,081 |
| P8 | Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies , BD Lehmann . et al. (2011). | 1,985 |
| P9 | The benefits and harms of breast cancer screening: an independent review, The Lancet (2012). | 821 |
| P10 | Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, A Prat. et al. (2010). | 1,341 |
| P11 | The treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, A Goldhirsch . et al. (2013). | 1,516 |
| P12 | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists , AC Wolff . et al. (2013). | 1,891 |
| P13 | Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial, AP Forrest et al. (1996). | 440 |
Score Computation of Cited Papers
| Paper ID | Citing paper | Cited Content | Cited Term | Score | Citation Score |
|---|---|---|---|---|---|
| P1 | Pan-cancer analysis of whole genomes, PJ Campbell et.al.2017 | Transcription factors and other proteins interact with enhancers, silencers, boundary elements, and overall chromatin structure for conferring cell-specific regulatory responses. Recent studies have revealed the greater relevance of this interplay in cancer. | More relevance | 0.85 | |
| DNA damage response gene mutations and inherited susceptibility to breast cancer, t mantere,2017 | Of late, large-scale DNA sequencing has helped the well systematic characterization of the full mutation repertoire in breast cancer, providing insights into the mutated cancer genes and mutational processes of the disease | Well systematic | 0.62 | ||
| A pan cancer analysis of promoter activity highlights the regulatory role of alternative transcription start sites and their association with noncoding mutations, D Demircioğlu et. al,2017 | One of the key properties of cancer is larger increase in mutation rates that can affect not only gene products, but also gene regulation | Increase larger in mutation | 0.82 | ||
| Systematic Identification and Analysis of Cell-state-associated c is regulatory Elements Using Statistical Approaches, Y Yang – 2017 | Aberrant c is regulatory elements in cancer are poorly characterized and understood | Poorly characterized | 0.45 | 2.94 |
Ranking of Cited Papers Based on Computed Cited Score
| Paper ID | Citation Score | Citation Ranking |
|---|---|---|
| P1 | 2.94 | 9 |
| P2 | 3.26 | 8 |
| P3 | 8.75 | 1 |
| P4 | 7.55 | 2 |
| P5 | 6.5 | 4 |
| P6 | 6.65 | 3 |
| P7 | 2.65 | 10 |
| P8 | 4.2 | 5 |
| P9 | 3.5 | 6 |
| P10 | 3.25 | 7 |
| P11 | 2.25 | 11 |
| P12 | 1.15 | 13 |
| P13 | 1.25 | 12 |
Comparison of Different Classifiers’ Results
| Training Citations (33,774)/ Testing Citations (168,870) | Total Citations | Positive Citations | Negative Citations | Neutral Citations | Undefined Citations | Accuracy |
|---|---|---|---|---|---|---|
| SSOACS | 168,870 | 126,270 | 1,350 | 5,040 | 36,210 | 74.78 |
| SSOACS | 168,870 | 121,620 | 1,410 | 4,920 | 40,920 | 72.03 |
| SSOACS | 168,870 | 121,260 | 1,380 | 5,040 | 41,190 | 71.82 |
| SSOACS | 168,870 | 120,990 | 1,380 | 3,510 | 42,990 | 71.65 |
| SSOACS | 168,870 | 118,770 | 1,170 | 5,010 | 43,920 | 70.33 |
| SSOACS | 168,870 | 117,090 | 1,440 | 3,960 | 46,380 | 69.34 |
| SSOACS | 168,870 | 116,490 | 1,440 | 5,040 | 45,900 | 68.11 |
| SSOACS | 168,870 | 114,180 | 1,440 | 3,780 | 49,470 | 67.33 |
Class-Wise Detailed Accuracy
| Classifiers | Detailed Accuracy | Positive | Negative | Undefined | Both |
|---|---|---|---|---|---|
| J48 | Precision | 0.767 | 0 | 0.322 | 0 |
| Recall | 0.933 | 0 | 0.423 | 0 | |
| F-measure | 0.842 | 0 | 0.643 | 0 | |
| Conjunctive Rule | Precision | 0.736 | 0 | 0.51 | 0 |
| Recall | 0.954 | 0 | 0.145 | 0 | |
| F-measure | 0.831 | 0 | 0.226 | 0 | |
| AdaBoostM1 | Precision | 0.718 | 0 | 0 | 0 |
| Recall | 1 | 0 | 0 | 0 | |
| F-measure | 0.836 | 0 | 0 | 0 | |
| Naïve Bayes | Precision | 0.718 | 0 | 0 | 0 |
| Recall | 1 | 0 | 0 | 0 | |
| F-measure | 0.836 | 0 | 0 | 0 | |
| SMO | Precision | 0.718 | 0 | 0 | 0 |
| Recall | 1 | 0 | 0 | 0 | |
| F-measure | 0.836 | 0 | 0 | 0 | |
| IBK Instance based | Precision | 0.773 | 0 | 0.536 | 0.04 |
| Recall | 0.826 | 0 | 0.407 | 0.07 | |
| F-measure | 0.799 | 0 | 0.463 | 0.06 | |
| Random Forest | Precision | 0.785 | 0 | 0.474 | 0.05 |
| Recall | 0.789 | 0 | 0.467 | 0.05 | |
| F-measure | 0.787 | 0 | 0.471 | 0.05 | |
| Random Tree | Precision | 0.785 | 0 | 0.469 | 0.04 |
| Recall | 0.782 | 0 | 0.469 | 0.04 | |
| F-measure | 0.783 | 0 | 0.469 | 0.06 |
Figure 2Citation Count Based Ranking between Cited Papers vs Citation Count
Figure 3Cited Papers vs Citation Score